117 related articles for article (PubMed ID: 38568838)
21. A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice.
Schoemaker MH; Kleemann R; Morrison MC; Verheij J; Salic K; van Tol EAF; Kooistra T; Wielinga PY
PLoS One; 2017; 12(7):e0180648. PubMed ID: 28678821
[TBL] [Abstract][Full Text] [Related]
22. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
[TBL] [Abstract][Full Text] [Related]
23. Bavachin protects against diet-induced hepatic steatosis and obesity in mice.
Wei X; Lin L; Yuan QQ; Wang XY; Zhang Q; Zhang XM; Tang KC; Guo MY; Dong TY; Han W; Huang DK; Qi YL; Zhang M; Zhang HB
Acta Pharmacol Sin; 2023 Jul; 44(7):1416-1428. PubMed ID: 36721007
[TBL] [Abstract][Full Text] [Related]
24. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis.
Matsumoto M; Hada N; Sakamaki Y; Uno A; Shiga T; Tanaka C; Ito T; Katsume A; Sudoh M
Int J Exp Pathol; 2013 Apr; 94(2):93-103. PubMed ID: 23305254
[TBL] [Abstract][Full Text] [Related]
25. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.
Ganz M; Csak T; Szabo G
World J Gastroenterol; 2014 Jul; 20(26):8525-34. PubMed ID: 25024607
[TBL] [Abstract][Full Text] [Related]
26. Aerobic training improves NAFLD markers and insulin resistance through AMPK-PPAR-α signaling in obese mice.
Diniz TA; de Lima Junior EA; Teixeira AA; Biondo LA; da Rocha LAF; Valadão IC; Silveira LS; Cabral-Santos C; de Souza CO; Rosa Neto JC
Life Sci; 2021 Feb; 266():118868. PubMed ID: 33310034
[TBL] [Abstract][Full Text] [Related]
27. (Pro)Renin Receptor Antagonism Attenuates High-Fat-Diet-Induced Hepatic Steatosis.
Gayban AJB; Souza LAC; Cooper SG; Regalado E; Kleemann R; Feng Earley Y
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671527
[TBL] [Abstract][Full Text] [Related]
28. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
[TBL] [Abstract][Full Text] [Related]
29. CD47 Deficiency in Mice Exacerbates Chronic Fatty Diet-Induced Steatohepatitis Through Its Role in Regulating Hepatic Inflammation and Lipid Metabolism.
Tao HC; Chen KX; Wang X; Chen B; Zhao WO; Zheng Y; Yang YG
Front Immunol; 2020; 11():148. PubMed ID: 32158445
[TBL] [Abstract][Full Text] [Related]
30. Effects of
Cho SY; Choi JS; Jung UJ
J Med Food; 2024 Mar; 27(3):242-249. PubMed ID: 38354279
[TBL] [Abstract][Full Text] [Related]
31. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.
Schumacher JD; Kong B; Pan Y; Zhan L; Sun R; Aa J; Rizzolo D; Richardson JR; Chen A; Goedken M; Aleksunes LM; Laskin DL; Guo GL
Toxicol Appl Pharmacol; 2017 Sep; 330():1-8. PubMed ID: 28673684
[TBL] [Abstract][Full Text] [Related]
32. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
[TBL] [Abstract][Full Text] [Related]
33. Dietary calamondin supplementation slows the progression of non-alcoholic fatty liver disease in C57BL/6 mice fed a high-fat diet.
Shimizu K; Egusa Y; Nishimuta S; Fukumura Y; Yoshimura M; Inomoto T; Terada T; Tomita K; Nishinaka T
Int J Food Sci Nutr; 2021 May; 72(3):335-347. PubMed ID: 32862731
[TBL] [Abstract][Full Text] [Related]
34. Differential effect of weight loss with low-fat diet or high-fat diet restriction on inflammation in the liver and adipose tissue of mice with diet-induced obesity.
Wang Q; Perrard XD; Perrard JL; Mansoori A; Raya JL; Hoogeveen R; Smith CW; Ballantyne CM; Wu H
Atherosclerosis; 2011 Nov; 219(1):100-8. PubMed ID: 21824616
[TBL] [Abstract][Full Text] [Related]
35. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
[TBL] [Abstract][Full Text] [Related]
36. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
Chai C; Cox B; Yaish D; Gross D; Rosenberg N; Amblard F; Shemuelian Z; Gefen M; Korach A; Tirosh O; Lanton T; Link H; Tam J; Permyakova A; Ozhan G; Citrin J; Liao H; Tannous M; Hahn M; Axelrod J; Arretxe E; Alonso C; Martinez-Arranz I; Betés PO; Safadi R; Salhab A; Amer J; Tber Z; Mengshetti S; Giladi H; Schinazi RF; Galun E
Gastroenterology; 2020 Sep; 159(3):999-1014.e9. PubMed ID: 32450149
[TBL] [Abstract][Full Text] [Related]
37. Elucidation of the Metabolic and Transcriptional Responses of an Oriental Herbal Medicine, Bangpungtongseong-san, to Nonalcoholic Fatty Liver Disease in Diet-Induced Obese Mice.
Choi JY; Kwon EY; Choi MS
J Med Food; 2019 Sep; 22(9):928-936. PubMed ID: 31390281
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
[TBL] [Abstract][Full Text] [Related]
39. Alternate-day fasting protects the livers of mice against high-fat diet-induced inflammation associated with the suppression of Toll-like receptor 4/nuclear factor κB signaling.
Yang W; Cao M; Mao X; Wei X; Li X; Chen G; Zhang J; Wang Z; Shi J; Huang H; Yao X; Liu C
Nutr Res; 2016 Jun; 36(6):586-93. PubMed ID: 27188904
[TBL] [Abstract][Full Text] [Related]
40. Semaglutide Has Beneficial Effects on Non-Alcoholic Steatohepatitis in Ldlr-/-.Leiden Mice.
Inia JA; Stokman G; Morrison MC; Worms N; Verschuren L; Caspers MPM; Menke AL; Petitjean L; Chen L; Petitjean M; Jukema JW; Princen HMG; van den Hoek AM
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]